SynthesisBMC cancer2020

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens.

Zev A Wainberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.